Literature DB >> 16686245

Chronic pain and aberrant drug-related behavior in the emergency department.

Knox H Todd1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16686245     DOI: 10.1111/j.1748-720x.2005.tb00542.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


× No keyword cloud information.
  6 in total

1.  Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.

Authors:  Kathryn Hawk; Gail D'Onofrio; David A Fiellin; Marek C Chawarski; Patrick G O'Connor; Patricia H Owens; Michael V Pantalon; Steven L Bernstein
Journal:  Acad Emerg Med       Date:  2017-12-26       Impact factor: 3.451

2.  Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.

Authors:  Michael F Fleming; James Davis; Steven D Passik
Journal:  Pain Med       Date:  2008-08-18       Impact factor: 3.750

Review 3.  An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision Medicine.

Authors:  Khuthala Mnika; Gift D Pule; Collet Dandara; Ambroise Wonkam
Journal:  OMICS       Date:  2016-09-16

4.  Genomics and pain research in sickle cell disease: an explanation of heterogeneity?

Authors:  Maxine Adegbola
Journal:  ISRN Nurs       Date:  2011-04-20

5.  Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample.

Authors:  Aaron D Dora-Laskey; Jason E Goldstick; Brooke J Arterberry; Suni Jo Roberts; Rebecca L Haffajee; Amy S B Bohnert; Rebecca M Cunningham; Patrick M Carter
Journal:  West J Emerg Med       Date:  2020-06-19

6.  A prospective study to compare serial changes in pain scores for patients with and without a history of frequent ED utilization.

Authors:  Ryan Joseph; Alainya Tomanec; Thomas McLaughlin; Jose Guardiola; Peter Richman
Journal:  Heliyon       Date:  2021-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.